BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 38230908)

  • 1. Unveiling the potential anti-cancer activity of calycosin against multivarious cancers with molecular insights: A promising frontier in cancer research.
    Sohel M; Zahra Shova FT; Shuvo S; Mahjabin T; Mojnu Mia M; Halder D; Islam H; Roman Mogal M; Biswas P; Saha HR; Sarkar BC; Mamun AA
    Cancer Med; 2024 Feb; 13(3):e6924. PubMed ID: 38230908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
    Sohel M
    Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali.
    Gao J; Liu ZJ; Chen T; Zhao D
    Pharm Biol; 2014 Sep; 52(9):1217-22. PubMed ID: 24635389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma.
    Tan J; Qin X; Liu B; Mo H; Wu Z; Yuan Z
    Biomed Pharmacother; 2020 Jun; 126():110096. PubMed ID: 32179199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic and biochemical findings disclosed anti-hepatic steatosis mechanism of calycosin.
    Cheng X; Liu N; Liu H; Huang N; Sun X; Zhang G
    Bioorg Chem; 2020 Jul; 100():103914. PubMed ID: 32417523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics and
    Xu H; Qin J; Qin L; Guo C; Yang B
    Front Endocrinol (Lausanne); 2022; 13():790619. PubMed ID: 35898453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo Study on Glioma Treatment Enhancement by Combining Temozolomide with Calycosin and Formononetin.
    Ni Q; Fan Y; Zhang X; Fan H; Li Y
    J Ethnopharmacol; 2019 Oct; 242():111699. PubMed ID: 31005632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
    Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
    Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targets and molecular mechanism of calycosin for the treatment of cerebral ischemia/reperfusion injury.
    Yu S; Wu K; Liang Y; Zhang H; Guo C; Yang B
    Aging (Albany NY); 2021 Jun; 13(12):16804-16815. PubMed ID: 34176787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the multi-targeting phytoestrogen potential of Calycosin for cancer treatment: A review.
    Ren F; Ma Y; Zhang K; Luo Y; Pan R; Zhang J; Kan C; Hou N; Han F; Sun X
    Medicine (Baltimore); 2024 May; 103(18):e38023. PubMed ID: 38701310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neoplastic characteristics and potential targets of calycosin against bisphenol A-related osteosarcoma: bioinformatics analysis.
    Pan Q; Wu K; Tan J; Li Y; Liang X; Su M
    Bioengineered; 2021 Dec; 12(1):4278-4288. PubMed ID: 34311656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calycosin-loaded nanoliposomes as potential nanoplatforms for treatment of diabetic nephropathy through regulation of mitochondrial respiratory function.
    Huang C; Xue LF; Hu B; Liu HH; Huang SB; Khan S; Meng Y
    J Nanobiotechnology; 2021 Jun; 19(1):178. PubMed ID: 34120609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calycosin Enhances Some Chemotherapeutic Drugs Inhibition of Akt Signaling Pathway in Gastric Cells.
    Zhou L; Wu Y; Guo Y; Li Y; Li N; Yang Y; Qin X
    Cancer Invest; 2017 May; 35(5):289-300. PubMed ID: 28368679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
    Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
    PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calycosin induces apoptosis by the regulation of ERβ/miR-17 signaling pathway in human colorectal cancer cells.
    Chen J; Zhao X; Li X; Wu Y
    Food Funct; 2015 Sep; 6(9):3091-7. PubMed ID: 26215320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dual roles of calycosin in growth inhibition and metastatic progression during pancreatic cancer development: A "TGF-β paradox".
    Zhang Z; Auyeung KK; Sze SC; Zhang S; Yung KK; Ko JK
    Phytomedicine; 2020 Mar; 68():153177. PubMed ID: 32106002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7.
    Tian J; Duan YX; Bei CY; Chen J
    Horm Metab Res; 2013 Aug; 45(8):593-8. PubMed ID: 23609007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study on the effect of promoting the osteogenic function of osteoblasts using isoflavones from Radix Astragalus.
    Kong X; Wang F; Niu Y; Wu X; Pan Y
    Phytother Res; 2018 Jan; 32(1):115-124. PubMed ID: 29044703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calycosin induces apoptosis in human ovarian cancer SKOV3 cells by activating caspases and Bcl-2 family proteins.
    Zhou Y; Liu QH; Liu CL; Lin L
    Tumour Biol; 2015 Jul; 36(7):5333-9. PubMed ID: 25672608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calycosin and genistein induce apoptosis by inactivation of HOTAIR/p-Akt signaling pathway in human breast cancer MCF-7 cells.
    Chen J; Lin C; Yong W; Ye Y; Huang Z
    Cell Physiol Biochem; 2015; 35(2):722-8. PubMed ID: 25613518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.